Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Chemical Therapeutics

Drugs that attack cancer cells have been and continue to be one of the most effective ways to fight cancer. Recent advances in cancer biology and molecular genetics have opened the door to a new era of drug therapy. The Chemical Therapeutics Program brings together faculty with strengths in chemistry, engineering, pharmacology, and clinical trials to translate this new knowledge about the cellular and molecular changes that drive the growth of cancer into effective chemically-based therapies. It is also home the Center’s Phase I Clinical Trials Program.  As a result, the Chemical Therapeutics Program is the nidus for translational investigators working to develop and evaluate novel agents and molecular-based diagnostics for cancer.  The Chemical Therapeutics Program leader is Philip Cole, M.D., Ph.D.

Physician Scientists

 
 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer